Consolidation with carfilzomib, lenalidomide, and dexamethasone (KRd) following ASCT results in high rates of minimal residual disease negativity and improves bone metabolism, in the absence of bisphosphonates, among newly diagnosed patients with multiple myeloma

被引：12

作者：

Gavriatopoulou, Maria ^{[1
]}

Terpos, Evangelos ^{[1
]}

Ntanasis-Stathopoulos, Ioannis ^{[1
]}

Malandrakis, Panagiotis ^{[1
]}

Eleutherakis-Papaiakovou, Evangelos ^{[1
]}

Papatheodorou, Athanasios ^{[2
]}

Kanellias, Nikolaos ^{[1
]}

Migkou, Magdalini ^{[1
]}

Fotiou, Despina ^{[1
]}

Dialoupi, Ioanna ^{[1
]}

Roussou, Maria ^{[1
]}

Kokkali, Nikoletta-Aikaterini ^{[1
]}

Kastritis, Efstathios ^{[1
]}

Dimopoulos, Meletios A. ^{[1
]}

机构：

[1] Natl & Kapodistrian Univ Athens, Sch Med, Dept Clin Therapeut, Athens, Greece

[2] 251 Gen Air Force Hosp, Dept Med Res, Athens, Greece

来源：

BLOOD CANCER JOURNAL | 2020年 / 10卷 / 03期

关键词：

TRANSPLANTATION; POSTTRANSPLANT; SURVIVAL; RISK;

D O I：

10.1038/s41408-020-0297-2

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页数：4

共 17 条

[1] Mechanism of Action of Bortezomib and the New Proteasome Inhibitors on Myeloma Cells and the Bone Microenvironment: Impact on Myeloma-Induced Alterations of Bone Remodeling [J].

Accardi, Fabrizio ;

Toscani, Denise ;

Bolzoni, Marina ;

Palma, Benedetta Dalla ;

Aversa, Franco ;

Giuliani, Nicola .

BIOMED RESEARCH INTERNATIONAL, 2015, 2015

[2]

[Anonymous], 2016, BLOOD

[3] Risk of Serious Infections with Carfilzomib in Patients with Multiple Myeloma: A Systematic Review and Meta-Analysis of Randomized Controlled Trials [J].

Ball, Somedeb ;

Behera, Tapas Ranjan ;

Wongsaengsak, Sariya ;

Khandelwal, Nuvneet ;

Chakraborty, Rajshekhar .

BLOOD, 2019, 134

[4] Daratumumab, Carfilzomib, Lenalidomide and Dexamethasone (Dara-KRd) Induction, Autologous Transplantation and Post-Transplant, Response-Adapted, Measurable Residual Disease (MRD)-Based Dara-Krd Consolidation in Patients with Newly Diagnosed Multiple Myeloma (NDMM) [J].

Costa, Luciano J. ;

Chhabra, Saurabh ;

Godby, Kelly N. ;

Medvedova, Eva ;

Cornell, Robert F. ;

Hall, Aric C. ;

Silbermann, Rebecca W. ;

Innis-Shelton, Racquel ;

Dhakal, Binod ;

DeIdiaquez, Diego ;

Hardwick, Pamela ;

Biru, Yelak ;

Omel, James L. ;

Hari, Parameswaran ;

Callander, Natalie Scott .

BLOOD, 2019, 134

[5]

GAY F, 2019, J CLIN ONCOL S, V37

[6] Carfilzomib-Lenalidomide-Dexamethasone (KRd) Induction-Autologous Transplant (ASCT)-Krd Consolidation Vs KRd 12 Cycles Vs Carfilzomib-Cyclophosphamide-Dexamethasone (KCd) Induction-ASCT-KCd Consolidation: Analysis of the Randomized Forte Trial in Newly Diagnosed Multiple Myeloma (NDMM) [J].

Gay, Francesca ;

Cerrato, Chiara ;

Scalabrini, Delia Rota ;

Galli, Monica ;

Belotti, Angelo ;

Zamagni, Elena ;

Ledda, Antonio ;

Grasso, Mariella ;

Angelucci, Emanuele ;

Liberati, Anna Marina ;

Tosi, Patrizia ;

Pisani, Francesco ;

Spada, Stefano ;

Annibali, Ombretta ;

Baraldi, Anna ;

Omede, Paola ;

Galieni, Piero ;

Rizzi, Rita ;

Pescosta, Norbert ;

Ronconi, Sonia ;

Vincelli, Donatella ;

Cafro, Anna Maria ;

Offidani, Massimo ;

Palumbo, Antonio ;

Musto, Pellegrino ;

Cavo, Michele ;

Boccadoro, Mario .

BLOOD, 2018, 132

[7]

Jakubowiak AJ, 2017, BLOOD, V130

[8] A phase 1/2 study of carfilzomib in combination with lenalidomide and low-dose dexamethasone as a frontline treatment for multiple myeloma [J].

Jakubowiak, Andrzej J. ;

Dytfeld, Dominik ;

Griffith, Kent A. ;

Lebovic, Daniel ;

Vesole, David H. ;

Jagannath, Sundar ;

Al-Zoubi, Ammar ;

Anderson, Tara ;

Nordgren, Brian ;

Detweiler-Short, Kristen ;

Stockerl-Goldstein, Keith ;

Ahmed, Asra ;

Jobkar, Terri ;

Durecki, Diane E. ;

McDonnell, Kathryn ;

Mietzel, Melissa ;

Couriel, Daniel ;

Kaminski, Mark ;

Vij, Ravi .

BLOOD, 2012, 120 (09) :1801-1809

[9] Treatment With Carfilzomib-Lenalidomide-Dexamethasone With Lenalidomide Extension in Patients With Smoldering or Newly Diagnosed Multiple Myeloma [J].

Korde, Neha ;

Roschewski, Mark ;

Zingone, Adriana ;

Kwok, Mary ;

Manasanch, Elisabet E. ;

Bhutani, Manisha ;

Tageja, Nishant ;

Kazandjian, Dickran ;

Mailankody, Sham ;

Wu, Peter ;

Morrison, Candis ;

Costello, Rene ;

Zhang, Yong ;

Burton, Debra ;

Mulquin, Marcia ;

Zuchlinski, Diamond ;

Lamping, Liz ;

Carpenter, Ashley ;

Wall, Yvonne ;

Carter, George ;

Cunningham, Schuyler C. ;

Gounden, Verena ;

Sissung, Tristan M. ;

Peer, Cody ;

Maric, Irina ;

Calvo, Katherine R. ;

Braylan, Raul ;

Yuan, Constance ;

Stetler-Stevenson, Maryalice ;

Arthur, Diane C. ;

Kong, Katherine A. ;

Weng, Li ;

Faham, Malek ;

Lindenberg, Liza ;

Kurdziel, Karen ;

Choyke, Peter ;

Steinberg, Seth M. ;

Figg, William ;

Landgren, Ola .

JAMA ONCOLOGY, 2015, 1 (06) :746-754

[10] Carfilzomib with immunomodulatory drugs for the treatment of newly diagnosed multiple myeloma [J].

Landgren, Ola ;

Sonneveld, Pieter ;

Jakubowiak, Andrzej ;

Mohty, Mohamad ;

Iskander, Karim S. ;

Mezzi, Khalid ;

Siegel, David S. .

LEUKEMIA, 2019, 33 (09) :2127-2143

← 1 2 →